End of BRCA patent dispute may be in sight

31 January 2012

Daniel Ravicher, executive director of PUBPAT, said: “Many scientists believe this case to be about critical questions of patient care and social policy. The decisions made in the lower court were highly fractious so this is precisely the kind of case the Supreme Court should hear”.

More from us

Genomics and policy news